These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 2546562

  • 1. Lack of competition between cytochrome c and anthraquinone type drugs for the reductive sites of NADH dehydrogenase.
    Tarasiuk J, Garnier-Suillerot A, Borowski E.
    Biochem Pharmacol; 1989 Jul 15; 38(14):2285-9. PubMed ID: 2546562
    [Abstract] [Full Text] [Related]

  • 2. Bis(alkylamino)anthracenedione antineoplastic agent metabolic activation by NADPH-cytochrome P-450 reductase and NADH dehydrogenase: diminished activity relative to anthracyclines.
    Kharasch ED, Novak RF.
    Arch Biochem Biophys; 1983 Jul 15; 224(2):682-94. PubMed ID: 6408991
    [Abstract] [Full Text] [Related]

  • 3. Anthracenedione activation by NADPH-cytochrome P-450 reductase; comparison with anthracyclines.
    Kharasch ED, Novak RF.
    Biochem Pharmacol; 1981 Oct 15; 30(20):2881-4. PubMed ID: 6274352
    [No Abstract] [Full Text] [Related]

  • 4. The essential role of anthraquinones as substrates for NADH dehydrogenase in their redox cycling activity.
    Tarasiuk J, Garnier-Suillerot A, Stefańska B, Borowski E.
    Anticancer Drug Des; 1992 Aug 15; 7(4):329-40. PubMed ID: 1324690
    [Abstract] [Full Text] [Related]

  • 5. The effect of rate limitation by cytochrome c on the redox state of the ubiquinone pool in reconstituted NADH: cytochrome c reductase.
    Reed JS, Ragan CI.
    Biochem J; 1987 Nov 01; 247(3):657-62. PubMed ID: 2827635
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Further studies on the in vivo effect of diisopropyl 1,3-dithiol-2-ylidenemalonate (NKK-105) on the liver microsomal drug oxidation system in rats.
    Katoh M, Kitada M, Satoh T, Kitagawa H, Sugimoto T, Kasai T.
    Biochem Pharmacol; 1981 Oct 01; 30(20):2759-65. PubMed ID: 6119083
    [No Abstract] [Full Text] [Related]

  • 14. The involvement of NADH-cytochrome b5 reductase and cytochrome b5 complex in microsomal NADH-cytochrome c reductase activity. Resolution of the complex by triton X-100.
    Starón K, Kaniuga Z.
    Acta Biochim Pol; 1974 Oct 01; 21(1):55-60. PubMed ID: 4364830
    [No Abstract] [Full Text] [Related]

  • 15. Metabolism of nitroxide spin labels in subcellular fraction of rat liver. I. Reduction by microsomes.
    Iannone A, Tomasi A, Vannini V, Swartz HM.
    Biochim Biophys Acta; 1990 Jun 20; 1034(3):285-9. PubMed ID: 2114173
    [Abstract] [Full Text] [Related]

  • 16. The reducing ability of iron chelates by NADH-cytochrome B5 reductase or cytochrome B5 responsible for NADH-supported lipid peroxidation.
    Miura A, Tampo Y, Yonaha M.
    Biochem Mol Biol Int; 1995 Sep 20; 37(1):141-50. PubMed ID: 8653076
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Low stimulation of NADH oxidation and oxygen consumption by 5-iminodaunorubicin and its derivatives.
    Tarasiuk J, Stefańska B, Borowski E.
    Acta Biochim Pol; 1990 Sep 20; 37(2):251-9. PubMed ID: 2072983
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.